APO 150 (Nizatidine 150 mg)
Pill imprint APO 150 has been identified as Nizatidine 150 mg.
Nizatidine is used in the treatment of gerd; duodenal ulcer; indigestion; erosive esophagitis; duodenal ulcer prophylaxis (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for APO 150 (Nizatidine 150 mg)
- 150 mg
- White & Yellow
- Rx and/or OTC
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Apotex Corp.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
ferric oxide yellow
|NDC Code||Manufacturer / Repackager|
|55045-3748||Dispensing Solutions Inc. (repackager)|
|55887-0153||Diversified Healthcare Services Inc (repackager)|
|23490-6010||Palmetto State Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.